玻璃体内注射贝伐单抗与全视网膜光凝治疗初治增殖性和重度非增殖性糖尿病视网膜病变的对比 - Suppr

Suppr

超能文献

Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.

作者信息

Ernst Benjamin J, García-Aguirre Gerardo, Oliver Scott C N, Olson Jeffrey L, Mandava Naresh, Quiroz-Mercado Hugo

出版信息

Acta Ophthalmol. 2012 Nov;90(7):e573-4. doi: 10.1111/j.1755-3768.2011.02364.x. Epub 2012 Mar 9.

DOI:10.1111/j.1755-3768.2011.02364.x

PMID:22405048

Abstract

摘要

相似文献

Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.玻璃体内注射贝伐单抗与全视网膜光凝治疗初治增殖性和重度非增殖性糖尿病视网膜病变的对比

Acta Ophthalmol. 2012 Nov;90(7):e573-4. doi: 10.1111/j.1755-3768.2011.02364.x. Epub 2012 Mar 9.

Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.全视网膜光凝后增生性糖尿病视网膜病变中新生血管持续存在时多次玻璃体内注射贝伐单抗（Avastin(®)）的治疗效果

Acta Ophthalmol. 2011 Feb;89(1):76-81. doi: 10.1111/j.1755-3768.2009.01622.x.

Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.全视网膜光凝 (PRP) 与 PRP 联合玻璃体内雷珠单抗治疗高危增殖性糖尿病视网膜病变。

Acta Ophthalmol. 2011 Nov;89(7):e567-72. doi: 10.1111/j.1755-3768.2011.02184.x. Epub 2011 Jul 5.

CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.全视网膜光凝联合玻璃体腔内注射贝伐单抗治疗增殖性糖尿病视网膜病变时脉络膜厚度的变化与单纯全视网膜光凝治疗的对比

Retina. 2016 Oct;36(10):1997-2005. doi: 10.1097/IAE.0000000000001027.

Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).雷珠单抗联合全视网膜光凝与单纯全视网膜光凝治疗高危增殖性糖尿病视网膜病变的比较（PROTEUS 研究）。

Ophthalmology. 2018 May;125(5):691-700. doi: 10.1016/j.ophtha.2017.12.008. Epub 2018 Feb 1.

Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.贝伐单抗（阿瓦斯汀）作为玻璃体切除术的辅助手段治疗严重增生性糖尿病视网膜病变：一项前瞻性病例系列研究。

Ophthalmic Res. 2011;45(1):23-30. doi: 10.1159/000314721. Epub 2010 Aug 11.

Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.接受全视网膜光凝与玻璃体内抗血管内皮生长因子治疗后随访丢失的增生性糖尿病视网膜病变眼的结局。

Ophthalmology. 2019 Mar;126(3):407-413. doi: 10.1016/j.ophtha.2018.07.027. Epub 2018 Aug 2.

Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.比较增生性糖尿病视网膜病变患者中雷珠单抗与全视网膜光凝治疗的中期安全性数据。

JAMA Ophthalmol. 2017 Jun 1;135(6):672-673. doi: 10.1001/jamaophthalmol.2017.0969.

Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.全视网膜光凝联合或不联合玻璃体内注射贝伐单抗治疗高危增殖性糖尿病视网膜病变的对比敏感度评估：一项随机临床试验。

Br J Ophthalmol. 2013 Jul;97(7):885-9. doi: 10.1136/bjophthalmol-2012-302675. Epub 2013 May 17.

Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.玻璃体内注射贝伐单抗治疗增生型和非增生型 2 型特发性黄斑毛细血管扩张症。

Retina. 2011 Oct;31(9):1848-55. doi: 10.1097/IAE.0b013e31820d3feb.

引用本文的文献

Meta-analysis: long/short-term efficacy of anti-VEGF vs. panretinal photocoagulation in preventing severe complications in proliferative diabetic retinopathy.荟萃分析：抗血管内皮生长因子与全视网膜光凝在预防增殖性糖尿病视网膜病变严重并发症方面的长期/短期疗效

Int J Retina Vitreous. 2025 Jul 9;11(1):76. doi: 10.1186/s40942-025-00687-0.

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.抗血管内皮生长因子治疗增生型糖尿病视网膜病变。

Cochrane Database Syst Rev. 2023 Mar 20;3(3):CD008721. doi: 10.1002/14651858.CD008721.pub3.

Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?抗血管内皮生长因子药物玻璃体腔内注射治疗糖尿病视网膜病变的疗效和安全性：我们已经学到了什么，还应该进一步学习什么？

Expert Opin Biol Ther. 2022 Oct;22(10):1275-1291. doi: 10.1080/14712598.2022.2100694. Epub 2022 Jul 17.

Assessment of retinal vascular oxygenation and morphology at stages of diabetic retinopathy in African Americans.评估非裔美国人糖尿病视网膜病变各期的视网膜血管氧合和形态。

BMC Ophthalmol. 2020 Jul 18;20(1):295. doi: 10.1186/s12886-020-01566-y.

Anti-Vascular Endothelial Growth Factor Therapy as an Alternative or Adjunct to Pan-Retinal Photocoagulation in Treating Proliferative Diabetic Retinopathy: Meta-Analysis of Randomized Trials.抗血管内皮生长因子疗法作为全视网膜光凝术的替代或辅助疗法治疗增殖性糖尿病视网膜病变：随机试验的荟萃分析

Front Pharmacol. 2020 Jun 5;11:849. doi: 10.3389/fphar.2020.00849. eCollection 2020.

Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy.使用商用扫描激光检眼镜测量糖尿病视网膜病变患者的视网膜血氧饱和度和血管直径

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5556-5563. doi: 10.1167/iovs.17-21934.

The effect of intravitreal vascular endothelial growth factor on inner retinal oxygen delivery and metabolism in rats.玻璃体内血管内皮生长因子对大鼠视网膜内层氧输送及代谢的影响。

Exp Eye Res. 2016 Feb;143:141-7. doi: 10.1016/j.exer.2015.09.018. Epub 2015 Oct 28.

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.抗血管内皮生长因子治疗增殖性糖尿病视网膜病变

Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008721. doi: 10.1002/14651858.CD008721.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验